Hach®, a global leader in water analysis and LuminUltra, a global leader in biological diagnostic testing, have partnered to offer the world’s first rapid, on-site testing solution for the detection of SARS-CoV-2 in wastewater. The partnership is a direct response to consumer and community need for same-day test results and accessible, cost-efficient solutions.
Made-in-Canada: LuminUltra’s rapid, portable qPCR solutions a game-changer for COVID-19 testing at Canada’s largest airport
The Greater Toronto Airport Authority announced that starting March 1 it will use LuminUltra’s game-changing rapid, portable COVID-19 qPCR testing solution on-site at Pearson International Airport, as part of a federally funded research study. The biotechnology front-runner’s GeneCount® COVID-19 RT-qPCR Assay Kit is authorized by Health Canada for sale and distribution.
Universal PropTech Inc. announces agreement with LuminUltra Technologies to provide SARS-CoV-2 (COVID-19) surface testing
Universal PropTech Inc. (TSXV: UPI) is pleased to announce that is has entered into an agreement with LuminUltra Technologies Ltd. to deploy LuminUltra’s GeneCount® Rapid SARS-CoV-2 surface testing solution for UPI’s current customers which total over 2,000 facilities in Canada today.
It’s more important than ever to be aware of the tests used in public health responses to viral outbreaks. In this post, we’ll discuss antigen, antibody, and PCR tests and how they’re used to detect SARS-CoV-2, the pathogen that causes COVID-19.
What is COVID-19 wastewater testing? How does it work, and who can benefit from it? Get answers to questions about this vital early-warning system.
(Halifax, NS) Researchers across Nova Scotia are launching a project aimed at detecting the presence of the virus that causes COVID-19 in human wastewater, helping to identify the potential presence of the virus quickly and before it can spread. Building on the recent results of a pilot study, the research team has begun to collect… Read More
Like many companies, when we launched our strategic plan in January, we had no idea what the year would hold. We will remember 2020 not only as a year of unprecedented challenges, but of resilience and innovation. In this post, we’ll cover some of the milestones that made this a truly monumental year for LuminUltra…. Read More
LuminUltra and BuiltSpace partner with UBC scientists to test cleaning protocols, reducing the risk of COVID-19 spread in indoor educational spaces
Vancouver, B.C. – Dec. 14, 2020 – Biotechnology leader LuminUltra has partnered with BuiltSpace, a building data and asset tracking specialist, and scientists at the University of British Columbia (UBC) to test the effectiveness of disinfection efforts in educational settings for early detection of SARS-CoV-2, the virus that causes COVID-19. “The battle against COVID-19 requires… Read More
Made-in-Canada COVID testing now available: LuminUltra receives Health Canada authorization for rapid, portable COVID-19 qPCR testing solutions
LuminUltra’s point-of-need and high-volume testing solutions capable of serving a range of COVID testing needs in under two hours FREDERICTON, NB, December 3, 2020 – Biotechnology front-runner LuminUltra is pleased to announce that it has received Health Canada authorization to sell and distribute its GeneCount® COVID-19 RT-qPCR Assay Kit. This authorization allows LuminUltra, the Canadian… Read More
LuminUltra expands testing capacity including range of COVID-19 offerings with acquisition of Source Molecular Corporation
FREDERICTON, NB, November 30, 2020 – Biotechnology front-runner LuminUltra today announced the acquisition of Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19. With this acquisition, LuminUltra has further expanded its range of molecular testing options for a variety of uses cases…. Read More